Th9 cells promote antitumor immune responses in vivo
Open accessThe DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Abstract
Th9 cells are a subset of CD4+ Th cells that produce the pleiotropic cytokine IL-9. IL-9/Th9 can function as both positive and negative regulators of immune response, but the role of IL-9/Th9 in tumor immunity is unknown. We examined the role of IL-9/Th9 in a model of pulmonary melanoma in mice. Lack of IL-9 enhanced tumor growth, while tumor-specific Th9 cell treatment promoted stronger antitumor responses in both prophylactic and therapeutic models. Th9 cells also elicited strong host antitumor CD8+ CTL responses by promoting Ccl20/Ccr6-dependent recruitment of DCs to the tumor tissues. Subsequent tumor antigen delivery to the draining LN resulted in CD8+ T cell priming. In agreement with this model, Ccr6 deficiency abrogated the Th9 cell-mediated antitumor response. Our data suggest a distinct role for tumor-specific Th9 cells in provoking CD8+ CTL-mediated antitumor immunity and indicate that Th9 cell-based cancer immunotherapy may be a promising therapeutic approach.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“IL-9 has been shown to favour CD8 T-cell activation in a model of pulmonary melanoma in mice36.”
From Selective degradation of PU.1 during autophagy represses the differentiation and antitumour activity of TH9 cells (2017) · cites this paper as [36]
The cited source says what the claim attributes to it.
In the citing paper
“This observation is in contrast to previous findings demonstrating a role of Th9 cells in controlling anti-tumour immune responses in solid tumours such as melanomas.26,27”
From PU.1-driven Th9 Cells Promote Colorectal Cancer in Experimental Colitis Models Through Il-6 Effects in Intestinal Epithelial Cells (2022) · cites this paper as [27]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Interferons, immunity and cancer immunoediting
Dunn, G. P., Koebel, C. M., & Schreiber, R. D. (2006) · Nature Reviews Immunology · doi:10.1038/nri1961 · Cited by 1,617
Differential Antigen Processing by Dendritic Cell Subsets in Vivo
Dudziak, D., Kamphorst, A. O., Heidkamp, G. F., Buchholz, V. R., Trumpfheller, C., Yamazaki, S., Cheong, C., Liu, K., Lee, H.-W., Park, C. G., et al. (2007) · Science · doi:10.1126/science.1136080 · Cited by 1,455
The Central Role of CD4+ T Cells in the Antitumor Immune Response
Hung, K., Hayashi, R., Lafond-Walker, A., Lowenstein, C., Pardoll, D., & Levitsky, H. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.12.2357 · Cited by 1,345
Veldhoen, M., Uyttenhove, C., van Snick, J., Helmby, H., Westendorf, A., Buer, J., Martin, B., Wilhelm, C., & Stockinger, B. (2008) · Nature Immunology · doi:10.1038/ni.1659 · Cited by 1,213
Dardalhon, V., Awasthi, A., Kwon, H., Galileos, G., Gao, W., Sobel, R. A., Mitsdoerffer, M., Strom, T. B., Elyaman, W., Ho, I.-C., et al. (2008) · Nature Immunology · doi:10.1038/ni.1677 · Cited by 1,122
Maldonado-López, R., De Smedt, T., Michel, P., Godfroid, J., Pajak, B., Heirman, C., Thielemans, K., Leo, O., Urbain, J., & Moser, M. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.3.587 · Cited by 984
Tumor-specific Th17-polarized cells eradicate large established melanoma
Muranski, P., Boni, A., Antony, P. A., Cassard, L., Irvine, K. R., Kaiser, A., Paulos, C. M., Palmer, D. C., Touloukian, C. E., Ptak, K., et al. (2008) · Blood · doi:10.1182/blood-2007-11-120998 · Cited by 845
IL-17 can promote tumor growth through an IL-6–Stat3 signaling pathway
Wang, L., Yi, T., Kortylewski, M., Pardoll, D. M., Zeng, D., & Yu, H. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20090207 · Cited by 842
Self-citationT Helper 17 Cells Promote Cytotoxic T Cell Activation in Tumor Immunity
Martin-Orozco, N., Muranski, P., Chung, Y., Yang, X. O., Yamazaki, T., Lu, S., Hwu, P., Restifo, N. P., Overwijk, W. W., & Dong, C. (2009) · Immunity · doi:10.1016/j.immuni.2009.09.014 · Cited by 800
Helping the CD8+ T-cell response
Bevan, M. J. (2004) · Nature Reviews Immunology · doi:10.1038/nri1413 · Cited by 797
Cited by
Sun, L., Su, Y., Jiao, A., Wang, X., & Zhang, B. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01471-y · Cited by 1,014
The γc Family of Cytokines: Basic Biology to Therapeutic Ramifications
Leonard, W. J., Lin, J.-X., & O'Shea, J. J. (2019) · Immunity · doi:10.1016/j.immuni.2019.03.028 · Cited by 383
The development and in vivo function of T helper 9 cells
Kaplan, M. H., Hufford, M. M., & Olson, M. R. (2015) · Nature Reviews Immunology · doi:10.1038/nri3824 · Cited by 384
Th9 cells: differentiation and disease
Kaplan, M. H. (2013) · Immunological Reviews · doi:10.1111/imr.12028 · Cited by 320
Chen, W. (2023) · Annual Review of Immunology · doi:10.1146/annurev-immunol-101921-045939 · Cited by 280
Role of Th17 cells in the pathogenesis of CNS inflammatory demyelination
Rostami, A., & Ciric, B. (2013) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2013.03.002 · Cited by 275
CD38-NAD+Axis Regulates Immunotherapeutic Anti-Tumor T Cell Response
Chatterjee, S., Daenthanasanmak, A., Chakraborty, P., Wyatt, M. W., Dhar, P., Selvam, S. P., Fu, J., Zhang, J., Nguyen, H., Kang, I., et al. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2017.10.006 · Cited by 270
USP15 stabilizes MDM2 to mediate cancer-cell survival and inhibit antitumor T cell responses
Zou, Q., Jin, J., Hu, H., Li, H. S., Romano, S., Xiao, Y., Nakaya, M., Zhou, X., Cheng, X., Yang, P., et al. (2014) · Nature Immunology · doi:10.1038/ni.2885 · Cited by 247
Self-citationTh9 Cells Drive Host Immunity against Gastrointestinal Worm Infection
Licona-Limón, P., Henao-Mejia, J., Temann, A. U., Gagliani, N., Licona-Limón, I., Ishigame, H., Hao, L., Herbert, D. R., & Flavell, R. A. (2013) · Immunity · doi:10.1016/j.immuni.2013.07.020 · Cited by 221
The transcription factor IRF1 dictates the IL-21-dependent anticancer functions of TH9 cells
Végran, F., Berger, H., Boidot, R., Mignot, G., Bruchard, M., Dosset, M., Chalmin, F., Rébé, C., Dérangère, V., Ryffel, B., et al. (2014) · Nature Immunology · doi:10.1038/ni.2925 · Cited by 228
Interleukin-1 as Innate Mediator of T Cell Immunity
Van Den Eeckhout, B., Tavernier, J., & Gerlo, S. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.621931 · Cited by 213
TGF-β in T Cell Biology: Implications for Cancer Immunotherapy
Dahmani, A., & Delisle, J.-S. (2018) · Cancers · doi:10.3390/cancers10060194 · Cited by 214
The Common Cytokine Receptor γ Chain Family of Cytokines
Lin, J.-X., & Leonard, W. J. (2018) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a028449 · Cited by 200
Human T H 9 Cells Are Skin-Tropic and Have Autocrine and Paracrine Proinflammatory Capacity
Schlapbach, C., Gehad, A., Yang, C., Watanabe, R., Guenova, E., Teague, J. E., Campbell, L., Yawalkar, N., Kupper, T. S., & Clark, R. A. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3007828 · Cited by 204
The multifaceted role of autophagy in cancer and the microenvironment
Folkerts, H., Hilgendorf, S., Vellenga, E., Bremer, E., & Wiersma, V. R. (2019) · Medicinal Research Reviews · doi:10.1002/med.21531 · Cited by 199
Th9 cells, new players in adaptive immunity
Schmitt, E., Klein, M., & Bopp, T. (2014) · Trends in Immunology · doi:10.1016/j.it.2013.10.004 · Cited by 189
T lymphocyte subsets in cancer immunity: Friends or foes
Chraa, D., Naim, A., Olive, D., & Badou, A. (2019) · Journal of Leukocyte Biology · doi:10.1002/jlb.mr0318-097r · Cited by 172
Lu, Y., Wang, Q., Xue, G., Bi, E., Ma, X., Wang, A., Qian, J., Dong, C., & Yi, Q. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.05.004 · Cited by 169
Self-citationCholesterol negatively regulates IL-9–producing CD8+ T cell differentiation and antitumor activity
Ma, X., Bi, E., Huang, C., Lu, Y., Xue, G., Guo, X., Wang, A., Yang, M., Qian, J., Dong, C., et al. (2018) · Journal of Experimental Medicine · doi:10.1084/jem.20171576 · Cited by 165
Self-citationKim, I.-K., Kim, B.-S., Koh, C.-H., Seok, J.-W., Park, J.-S., Shin, K.-S., Bae, E.-A., Lee, G.-E., Jeon, H., Cho, J., et al. (2015) · Nature Medicine · doi:10.1038/nm.3922 · Cited by 167
Self-citationEngineered Cytokine Signaling to Improve CAR T Cell Effector Function
Bell, M. R., & Gottschalk, S. M. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.684642 · Cited by 173
Yan, D., Adeshakin, A. O., Xu, M., Afolabi, L. O., Zhang, G., Chen, Y. H., & Wan, X. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01399 · Cited by 170
Liao, W., Spolski, R., Li, P., Du, N., West, E. E., Ren, M., Mitra, S., & Leonard, W. J. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1301138111 · Cited by 155
Zhang, J., Ramadan, A. M., Griesenauer, B., Li, W., Turner, M. J., Liu, C., Kapur, R., Hanenberg, H., Blazar, B. R., Tawara, I., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aab0166 · Cited by 166
Zhao, Y., Chu, X., Chen, J., Wang, Y., Gao, S., Jiang, Y., Zhu, X., Tan, G., Zhao, W., Yi, H., et al. (2016) · Nature Communications · doi:10.1038/ncomms12368 · Cited by 159
Self-citationLu, Y., Hong, B., Li, H., Zheng, Y., Zhang, M., Wang, S., Qian, J., & Yi, Q. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1317431111 · Cited by 146
Self-citationImmunopathobiology and therapeutic targets related to cytokines in liver diseases
He, Y., Hwang, S., Ahmed, Y. A., Feng, D., Li, N., Ribeiro, M., Lafdil, F., Kisseleva, T., Szabo, G., & Gao, B. (2021) · Cellular & Molecular Immunology · doi:10.1038/s41423-020-00580-w · Cited by 137
T Cell Subsets in Graft Versus Host Disease and Graft Versus Tumor
Jiang, H., Fu, D., Bidgoli, A., & Paczesny, S. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.761448 · Cited by 149
Antunes, R. D. S., Babor, M., Carpenter, C., Khalil, N. N., Cortese, M., Mentzer, A. J., Seumois, G., Petro, C. D., Purcell, L. A., Vijayanand, P., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci121309 · Cited by 140
IL-9-producing T cells: potential players in allergy and cancer
Angkasekwinai, P., & Dong, C. (2020) · Nature reviews. Immunology · doi:10.1038/s41577-020-0396-0 · Cited by 138
The Pleiotropic Immunomodulatory Functions of IL-33 and Its Implications in Tumor Immunity
Afferni, C., Buccione, C., Andreone, S., Galdiero, M. R., Varricchi, G., Marone, G., Mattei, F., & Schiavoni, G. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02601 · Cited by 137
Potentiating adoptive cell therapy using synthetic IL-9 receptors
Kalbasi, A. K., Siurala, M., Su, L., Tariveranmoshabad, M., Picton, L. K., Ravikumar, P., Li, P., Lin, J., Escuin-Ordinas, H., Da, T., et al. (2022) · Nature · doi:10.1038/s41586-022-04801-2 · Cited by 131
GITR subverts Foxp3+ Tregs to boost Th9 immunity through regulation of histone acetylation
Xiao, X., Shi, X., Fan, Y., Zhang, X., Wu, M., Lan, P., Minze, L. J., Fu, Y., Ghobrial, R. M., Liu, W., et al. (2015) · Nature Communications · doi:10.1038/ncomms9266 · Cited by 120
Xue, G., Jin, G., Fang, J., & Lu, Y. (2019) · Nature Communications · doi:10.1038/s41467-019-09401-9 · Cited by 107
Self-citationThe CD4-centered universe of human T cell subsets
Geginat, J., Paroni, M., Facciotti, F., Gruarin, P., Kastirr, I., Caprioli, F., Pagani, M., & Abrignani, S. (2013) · Seminars in Immunology · doi:10.1016/j.smim.2013.10.012 · Cited by 144
Liu, L., Bi, E., Ma, X., Xiong, W., Qian, J., Ye, L., Pan, S., Wang, Q., Xiao, L., Yang, M., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-19672-2 · Cited by 113
Self-citationFueling Cancer Immunotherapy With Common Gamma Chain Cytokines
Dwyer, C. J., Knochelmann, H. M., Smith, A. S., Wyatt, M. M., Rangel Rivera, G. O., Arhontoulis, D. C., Bartee, E., Li, Z., Rubinstein, M. P., & Paulos, C. M. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00263 · Cited by 108
Butyrate Attenuates Lung Inflammation by Negatively Modulating Th9 Cells
Vieira, R. D. S., Castoldi, Â., Basso, P. J., Hiyane, M. I., Câmara, N. O. S., & Almeida, R. R. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00067 · Cited by 104
An overview of the tumor microenvironment, from cells to complex networks (Review)
Farc, O., & Cristea, V. (2020) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2020.9528 · Cited by 107
TH9 cells in anti-tumor immunity
Vargas, T. R., Humblin, É., Végran, F., Ghiringhelli, F., & Apétoh, L. (2016) · Seminars in Immunopathology · doi:10.1007/s00281-016-0599-4 · Cited by 98
IL-9 and Th9 cells in health and diseases—From tolerance to immunopathology
Li, J., Chen, S., Xiao, X., Zhao, Y. L., Ding, W., & Li, X. C. (2017) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2017.07.004 · Cited by 96
Th9 Cells: A Novel CD4 T-cell Subset in the Immune War against Cancer
Végran, F., Apétoh, L., & Ghiringhelli, F. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-2748 · Cited by 96
IL-9 and IL-9-producing cells in tumor immunity
Wan, J., Wu, Y., Ji, X., Huang, L. J., Cai, W., Su, Z., Wang, S., & Xu, H. (2020) · Cell Communication and Signaling · doi:10.1186/s12964-020-00538-5 · Cited by 90
Autophagy in the crosstalk between tumor and microenvironment
Camuzard, O., Santucci‐Darmanin, S., Carle, G. F., & Pierrefite‐Carle, V. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.06.015 · Cited by 92
Targeting ubiquitin signaling for cancer immunotherapy
Zhou, X., & Sun, S. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00421-2 · Cited by 100
Rivera Vargas, T., Cai, Z., Shen, Y., Dosset, M., Benoit-Lizon, I., Martin, T., Roussey, A., Flavell, R. A., Ghiringhelli, F., & Apetoh, L. (2017) · Nature Communications · doi:10.1038/s41467-017-00468-w · Cited by 87
Nonomura, Y., Otsuka, A., Nakashima, C., Seidel, J. A., Kitoh, A., Dainichi, T., Nakajima, S., Sawada, Y., Matsushita, S., Aoki, M., et al. (2016) · OncoImmunology · doi:10.1080/2162402x.2016.1248327 · Cited by 83
Human Vδ2 T cells are a major source of interleukin-9
Peters, C., Häsler, R., Wesch, D., & Kabelitz, D. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1607136113 · Cited by 88
IL-9 and Th9 cells: progress and challenges
Zhao, P., Xiao, X., Ghobrial, R. M., & Li, X. C. (2013) · International Immunology · doi:10.1093/intimm/dxt039 · Cited by 85
The DNA-binding inhibitor Id3 regulates IL-9 production in CD4+ T cells
Nakatsukasa, H., Zhang, D., Maruyama, T., Chen, H., Cui, K., Ishikawa, M., Deng, L., Zanvit, P., Tu, E., Jin, W., et al. (2015) · Nature Immunology · doi:10.1038/ni.3252 · Cited by 80
Niccolai, E., Russo, E., Baldi, S., Ricci, F., Nannini, G., Pedone, M., Stingo, F. C., Taddei, A., Ringressi, M. N., Bechi, P., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.573158 · Cited by 86
Martínez-Sánchez, M. E., Huerta, L., Alvarez-Buylla, E. R., & Villarreal, C. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00877 · Cited by 91
Ruocco, G., Rossi, S., Motta, C., Macchiarulo, G., Barbieri, F. R., Bardi, M. D., Borsellino, G., Finardi, A., Grasso, M. G., Ruggieri, S., et al. (2015) · Clinical Science · doi:10.1042/cs20140608 · Cited by 81
Th9 Cell Differentiation and Its Dual Effects in Tumor Development
Chen, T., Guo, J., Cai, Z., Li, B., Sun, L., Shen, Y., Wang, S., Wang, Z., Wang, Z., Wang, Y., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01026 · Cited by 85
Martínez-Sánchez, M. E., Mendoza, L., Villarreal, C., & Alvarez-Buylla, E. R. (2015) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1004324 · Cited by 81
Guidance of super-enhancers in regulation of IL-9 induction and airway inflammation
Xiao, X., Fan, Y., Li, J., Zhang, X., Lou, X., Dou, Y., Shi, X., Lan, P., Xiao, Y., Minze, L. J., et al. (2018) · The Journal of Experimental Medicine · doi:10.1084/jem.20170928 · Cited by 76
Roth, S., Zamzow, K., Gaida, M. M., Heikenwälder, M. F., Tjaden, C., Hinz, U., Bose, P., Michalski, C. W., & Hackert, T. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2020.102714 · Cited by 75
Topchyan, P., Lin, S., & Cui, W. (2023) · Immune Network · doi:10.4110/in.2023.23.e41 · Cited by 80
Th17 cell function in cancers: immunosuppressive agents or anti-tumor allies?
Taghizadeh-Anvar, M., Rashidan, K., Arsam, N., Rasouli‐Saravani, A., Yadegari, H., Ahmadi, A., Asgari, Z., Vanan, A. G., Ghorbaninezhad, F., & Tahmasebi, S. (2024) · Cancer Cell International · doi:10.1186/s12935-024-03525-9 · Cited by 77
IL-9 aggravates the development of atherosclerosis in ApoE-/- mice
Zhang, W., Tang, T., Nie, D., Wen, S., Jia, C., Zhu, Z., Xia, N., Nie, S., Zhou, S., Jiao, J., et al. (2015) · Cardiovascular Research · doi:10.1093/cvr/cvv110 · Cited by 74
IL-9, a local growth factor for synovial T cells in inflammatory arthritis
Kundu‐Raychaudhuri, S., Abria, C. J., & Raychaudhuri, S. P. (2016) · Cytokine · doi:10.1016/j.cyto.2015.12.020 · Cited by 73
Chowdhury, K., Kumar, U., Das, S., Chaudhuri, J., Kumar, P., Kanjilal, M., Ghosh, P., Sircar, G., Basyal, R. K., Kanga, U., et al. (2018) · Arthritis Research & Therapy · doi:10.1186/s13075-017-1505-8 · Cited by 74
IL‐9 inhibits HTB‐72 melanoma cell growth through upregulation of p21 and TRAIL
Fang, Y., Chen, X., Bai, Q., Qin, C., Mohamud, A. O., Zhu, Z., Ball, T. W., Ruth, C. M., Newcomer, D. R., Herrick, E. J., et al. (2015) · Journal of Surgical Oncology · doi:10.1002/jso.23930 · Cited by 72
A tumour‐promoting role of Th9 cells in hepatocellular carcinoma through CCL20 and STAT3 pathways
Tan, H., Wang, S., & Zhao, L. (2017) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.12689 · Cited by 75
EGFR-HIF1α signaling positively regulates the differentiation of IL-9 producing T helper cells
Roy, S., Rizvi, Z. A., Clarke, A. J., Macdonald, F., Pandey, A., Zaiss, D. M. W., Simon, A. K., & Awasthi, A. (2021) · Nature Communications · doi:10.1038/s41467-021-23042-x · Cited by 74
HIV persistence in subsets of CD4+ T cells: 50 shades of reservoirs
Fromentin, R., & Chomont, N. (2020) · Seminars in Immunology · doi:10.1016/j.smim.2020.101438 · Cited by 76
Role and Potential of Different T Helper Cell Subsets in Adoptive Cell Therapy
Andreu-Sanz, D., & Kobold, S. (2023) · Cancers · doi:10.3390/cancers15061650 · Cited by 75
You, F., Zhang, J., Cui, T., Zhu, R., Lv, C., Tang, H., & Sun, D. (2017) · International Immunopharmacology · doi:10.1016/j.intimp.2017.08.031 · Cited by 75
TNF-α enhances Th9 cell differentiation and antitumor immunity via TNFR2-dependent pathways
Jiang, Y., Chen, J., Bi, E., Zhao, Y., Qin, T., Wang, Y., Wang, A., Gao, S., Yi, Q., & Wang, S. (2019) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-018-0494-8 · Cited by 68
Self-citationIRF8‐dependent Molecular Complexes Control the Th9 Transcriptional Program
Humblin, E., Thibaudin, M., Chalmin, F., Derangère, V., Limagne, E., Richard, C., Flavell, R. A., Chevrier, S., Ladoire, S., Berger, H., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-01070-w · Cited by 67
Suárez, G., Romero–Gallo, J., Piazuelo, M. B., Sierra, J. C., Delgado, A. G., Washington, M. K., Shah, S. C., Wilson, K. T., & Peek, R. M. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-2651 · Cited by 69
Anuradha, R., George, P. J., Hanna, L. E., Chandrasekaran, V., Kumaran, P., Nutman, T. B., & Babu, S. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1300911 · Cited by 67
Interleukin-1 (IL-1) and the inflammasome in cancer
Prêtre, V., Papadopoulos, D., Regard, J. B., Pelletier, M. R., & Woo, J. (2022) · Cytokine · doi:10.1016/j.cyto.2022.155850 · Cited by 70
IRF8: Mechanism of Action and Health Implications
Moorman, H. R., Reategui-Almonacid, Y., Poschel, D. B., & Liu, K. (2022) · Cells · doi:10.3390/cells11172630 · Cited by 70
T Helper 9 Cells: A New Player in Immune-Related Diseases
Chen, J., Guan, L., Tang, L., Liu, S., Zhou, Y., Chen, C., He, Z., & Xu, L. (2019) · DNA and Cell Biology · doi:10.1089/dna.2019.4729 · Cited by 71
Bi, E., Ma, X., Lu, Y., Yang, M., Wang, Q., Xue, G., Qian, J., Wang, S., & Yi, Q. (2017) · Science Signaling · doi:10.1126/scisignal.aak9741 · Cited by 65
Self-citationSpolski, R. J., Gromer, D. J., & Leonard, W. J. (2017) · F1000Research · doi:10.12688/f1000research.12202.1 · Cited by 73
Xue, G., Zheng, N., Fang, J., Jin, G., Li, X., Dotti, G., Yi, Q., & Lu, Y. (2021) · Cancer Cell · doi:10.1016/j.ccell.2021.09.011 · Cited by 66
Self-citationHarnessing Antitumor CD4+ T Cells for Cancer Immunotherapy
Khelil, M. B., Godet, Y., Abdeljaoued, S., Borg, C., Adotévi, O., & Loyon, R. (2022) · Cancers · doi:10.3390/cancers14010260 · Cited by 68
Clark, R. A., & Schlapbach, C. (2016) · Seminars in Immunopathology · doi:10.1007/s00281-016-0607-8 · Cited by 71
TGFβ in T cell biology and tumor immunity: Angel or devil?
Tu, E., Chia, P. Z. C., & Chen, W. (2014) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2014.07.014 · Cited by 67
The Regulatory Effects of mTOR Complexes in the Differentiation and Function of CD4 + T Cell Subsets
Wang, P., Zhang, Q., Tan, L., Xu, Y., Xie, X., & Zhao, Y. X. (2020) · Journal of Immunology Research · doi:10.1155/2020/3406032 · Cited by 71
The outstanding antitumor capacity of CD4+ T helper lymphocytes
Li, T., Wu, B., Yang, T., Zhang, L., & Jin, K. (2020) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2020.188439 · Cited by 63
TGF-β enhances the cytotoxic activity of Vδ2 T cells
Peters, C., Meyer, A., Kouakanou, L., Feder, J., Schricker, T., Lettau, M., Janßen, O., Wesch, D., & Kabelitz, D. (2018) · OncoImmunology · doi:10.1080/2162402x.2018.1522471 · Cited by 68
Circulating Th22 and Th9 Levels in Patients with Acute Coronary Syndrome
Lin, Y., Wu, B., Lu, Z., Huang, Y., Shi, Y., Liu, H., Liu, L., Zeng, Q.-T., Wang, X., & Ji, Q. (2013) · Mediators of Inflammation · doi:10.1155/2013/635672 · Cited by 59
Reducing CD73 Expression by IL1β-Programmed Th17 Cells Improves Immunotherapeutic Control of Tumors
Chatterjee, S., Thyagarajan, K., Kesarwani, P., Song, J. H., Soloshchenko, M., Fu, J., Bailey, S. R., Vasu, C., Kraft, A. S., Paulos, C. M., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-1450 · Cited by 56
Specifically differentiated T cell subset promotes tumor immunity over fatal immunity
Ramadan, A. M., Griesenauer, B., Adom, D., Kapur, R., Hanenberg, H., Liu, C., Kaplan, M. H., & Paczesny, S. (2017) · The Journal of Experimental Medicine · doi:10.1084/jem.20170041 · Cited by 57
The role of CD4+ T cells in tumor and chronic viral immune responses
Xie, L., Fang, J., Yu, J., Zhang, W., He, Z., Ye, L., & Wang, H. (2023) · MedComm · doi:10.1002/mco2.390 · Cited by 62
Murine Th9 cells promote the survival of myeloid dendritic cells in cancer immunotherapy
Park, J., Li, H., Zhang, M., Lu, Y., Hong, B., Zheng, Y., He, J., Yang, J., Qian, J., & Yi, Q. (2014) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-014-1557-4 · Cited by 56
Self-citationAbdul‐Wahid, A., Cydzik, M., Prodeus, A., Alwash, M., Stanojcic, M., Thompson, M., Huang, E. H. ‐., Shively, J. E., Gray‐Owen, S. D., & Gariépy, J. (2016) · International Journal of Cancer · doi:10.1002/ijc.30121 · Cited by 57
CD96 expression determines the inflammatory potential of IL-9–producing Th9 cells
Stanko, K., Iwert, C., Appelt, C., Vogt, K., Schumann, J., Strunk, F. J., Ahrlich, S., Schlickeiser, S., Romagnani, C., Jürchott, K., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1708329115 · Cited by 55
Cell-Intrinsic Roles for Autophagy in Modulating CD4 T Cell Functions
Jacquin, É., & Apétoh, L. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01023 · Cited by 54
Chen, J., Zhao, Y., Jiang, Y., Gao, S., Wang, Y., Wang, D., Wang, A., Yi, H., Gu, R., Yi, Q., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01787 · Cited by 52
Self-citationFas signaling-mediated TH9 cell differentiation favors bowel inflammation and antitumor functions
Shen, Y., Song, Z., Lu, X., Ma, Z., Lu, C., Zhang, B., Chen, Y., Duan, M., Apétoh, L., Xu, L., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-10889-4 · Cited by 55
Epigenetic Regulation: A Link between Inflammation and Carcinogenesis
Vezzani, B., Carinci, M., Previati, M., Giacovazzi, S., Sala, M. D., Gafà, R., Lanza, G., Wieckowski, M. R., Pinton, P., & Giorgi, C. (2022) · Cancers · doi:10.3390/cancers14051221 · Cited by 55
Targeting the IL-9 pathway in cancer immunotherapy
Zheng, N., & Lu, Y. (2020) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2019.1710413 · Cited by 50
Self-citationHoelzinger, D. B., Dominguez, A. L., Cohen, P. A., & Gendler, S. J. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-0836 · Cited by 51
Wang, C., Lu, Y., Chen, L., Gao, T., Yang, Q., Zhu, C., & Chen, Y. (2019) · International Immunopharmacology · doi:10.1016/j.intimp.2019.106019 · Cited by 52
Self-citationFriend or Foe? The Ambiguous Role of Innate Lymphoid Cells in Cancer Development
Mattner, J., & Wirtz, S. J. (2016) · Trends in Immunology · doi:10.1016/j.it.2016.10.004 · Cited by 52
STAT5 promotes accessibility and is required for BATF-mediated plasticity at the Il9 locus
Fu, Y., Wang, J., Panangipalli, G., Ulrich, B. J., Koh, B., Xu, C., Kharwadkar, R. P., Chu, X., Wang, Y., Gao, H., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-18648-6 · Cited by 52
Metadata
- Authors
- Lu, Y., Hong, S., Li, H., Park, J., Hong, B., Wang, L., Zheng, Y., Liu, Z., Xu, J., He, J., Yang, J., Qian, J., & Yi, Q.
- Affiliations
- The University of Texas MD Anderson Cancer Center (US)
- Corresponding author
- Yi, Qing
- ORCID
- Venue
- Journal of Clinical Investigation
- Published
- 2012-10-15
- Volume
- 122
- Issue
- 11
- Pages
- 4160-4171
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC3484462
- OpenAlex
- W2066906123
- Cited by
- 361
- References
- 50
- Citations by year
- 2026: 13 · 2025: 22 · 2024: 19 · 2023: 25 · 2022: 27 · 2021: 24 · 2020: 33 · 2019: 37 · 2018: 35 · 2017: 34 · 2016: 34 · 2015: 26 · 2014: 18 · 2013: 13 · 2012: 1
- FWCI
- 8.08
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Clinical Investigation (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Multiple Myeloma Research Foundation
- Commonwealth Foundation
- Leukemia and Lymphoma Society
- University of Texas MD Anderson Cancer Center
- National Cancer Institute (R01CA138402, R01CA138398, R01CA163881, P50CA142509, P30CA016672)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Keywords
- Th9 cells, IL-9, antitumor immunity, pulmonary melanoma, CD8+ cytotoxic T lymphocytes, dendritic cell recruitment, tumor antigen delivery, draining lymph nodes, cancer immunotherapy, CD4+ T cells
- MeSH terms
- Animals, Dendritic Cells, T-Lymphocytes, Helper-Inducer, Immunity, Cellular, Immunotherapy, Lung Neoplasms, Melanoma, Interleukin-9, Antigen Presentation, Mice, Knockout, CD8-Positive T-Lymphocytes, Cell Line, Tumor, Mice, Receptors, CCR6, Chemokine CCL20
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.